NSAIDs and heart failure
This article was originally published in The Tan Sheet
Executive Summary
NSAIDs users had a 30% increased risk of first hospital admission for heart failure (HF) compared to the general population in a study published recently in the British journal Heart. The nested case-control study included 228,660 patients in a cohort from the general UK population between the ages of 60 and 84 who were enrolled with a general practitioner for at least two years and had one year since their first computerized prescription, Consuelo Huerta, Centro Español de Investigació Farmacoepidemiológica, Madrid, Spain, et al., explain. The study results are consistent with previous research that suggests NSAIDs worsen symptoms of heart failure that results in hospitalization among high-risk patients, "but also that NSAIDs trigger the risk of HF hospitalization in patients without a history of clinical HF," the authors state. One of the studies weaknesses includes an absence of information on OTC drug use, although the study accurately captured Rx NSAID use through the UK computerized prescription database, Huerta et al. state...
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.